Germline and somatic variations influence the somatic mutational signatures of esophageal squamous cell carcinomas in a Chinese population

[1]  H. Matsubara,et al.  ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma , 2017, Oncology.

[2]  Jean-François Deleuze,et al.  Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis , 2017, Nature Communications.

[3]  Michael Jones,et al.  Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer , 2017, Nature Genetics.

[4]  E. Lander,et al.  A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer , 2017, Nature Genetics.

[5]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[6]  S. Law,et al.  Whole‐exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma , 2017, The Journal of pathology.

[7]  H. Matsubara,et al.  ZNF750 Expression as a Novel Candidate Biomarker of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma , 2017, Oncology.

[8]  E. Birney,et al.  HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures , 2017, Nature Medicine.

[9]  P. Gibbard,et al.  Anthropocene: keep communication clear , 2017, Nature.

[10]  David J. Barry,et al.  APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability. , 2017, Cancer discovery.

[11]  Benjamin J. Raphael,et al.  Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.

[12]  D. Lin,et al.  ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma , 2016, Oncogene.

[13]  Xin Xu,et al.  Spatial intratumor heterogeneity of genetic, epigenetic alterations and temporal clonal evolution in esophageal squamous cell carcinoma , 2016, Nature Genetics.

[14]  X. Hua,et al.  An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer , 2016, British Journal of Cancer.

[15]  Nicola D. Roberts,et al.  Germline MC1R status influences somatic mutation burden in melanoma , 2016, Nature Communications.

[16]  H. Aburatani,et al.  Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. , 2016, Gastroenterology.

[17]  Gad Getz,et al.  Somatic ERCC2 Mutations Are Associated with a Distinct Genomic Signature in Urothelial Tumors , 2016, Nature Genetics.

[18]  B. Taylor,et al.  deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.

[19]  Jiansheng Guo,et al.  Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma , 2016, GigaScience.

[20]  K. Somasundaram,et al.  Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing , 2015, Oncotarget.

[21]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[22]  James Y. Dai,et al.  Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma , 2015, Human Genomics.

[23]  Zhen-bo Feng,et al.  Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[24]  M. Stephens,et al.  A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures , 2015, bioRxiv.

[25]  Huanming Yang,et al.  Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma , 2015, American journal of human genetics.

[26]  Trevor J Pugh,et al.  Oncotator: Cancer Variant Annotation Tool , 2015, Human mutation.

[27]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[28]  Benjamin J. Raphael,et al.  Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.

[29]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[30]  J. Ferlay,et al.  Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.

[31]  Jian Sun,et al.  Genetic landscape of esophageal squamous cell carcinoma , 2014, Nature Genetics.

[32]  M. Rubin,et al.  Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men , 2014, Clinical Cancer Research.

[33]  Serena Nik-Zainal,et al.  Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.

[34]  S. Misra,et al.  Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. , 2014, World journal of gastrointestinal oncology.

[35]  Li Shang,et al.  Genomic and molecular characterization of esophageal squamous cell carcinoma , 2014, Nature Genetics.

[36]  Qiang Feng,et al.  Identification of genomic alterations in oesophageal squamous cell cancer , 2014, Nature.

[37]  M. Stratton,et al.  Mutational signatures: the patterns of somatic mutations hidden in cancer genomes , 2014, Current opinion in genetics & development.

[38]  David E Larson,et al.  Using VarScan 2 for Germline Variant Calling and Somatic Mutation Detection , 2013, Current protocols in bioinformatics.

[39]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[40]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[41]  Iuliana Ionita-Laza,et al.  Sequence kernel association tests for the combined effect of rare and common variants. , 2013, American journal of human genetics.

[42]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[43]  M. Stratton,et al.  Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.

[44]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[45]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[46]  A. Børresen-Dale,et al.  The Life History of 21 Breast Cancers , 2012, Cell.

[47]  M. Lai,et al.  Identification of distinct gene expression profiles between esophageal squamous cell carcinoma and adjacent normal epithelial tissues. , 2012, The Tohoku journal of experimental medicine.

[48]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[49]  Dana Pe'er,et al.  JISTIC: Identification of Significant Targets in Cancer , 2010, BMC Bioinformatics.

[50]  Liyu Cao,et al.  Expression and clinical significance of S100A2 and p63 in esophageal carcinoma. , 2009, World journal of gastroenterology.

[51]  N. Hu,et al.  Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China , 2009, BMC Cancer.

[52]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[53]  Cai,et al.  Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. , 2016 .

[54]  F. Kim,et al.  The Cancer , 2015, International braz j urol : official journal of the Brazilian Society of Urology.

[55]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[56]  Trevor J Pugh,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[57]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..